Chief Healthcare Executive October 12, 2023
Federal agencies will allow remote prescriptions to continue through 2024. Advocates say they are gearing up to ensure telehealth provisions can last even longer.
Federal agencies delivered the news telehealth advocates had been seeking.
Actually, they may have exceeded expectations.
The Drug Enforcement Administration and the Department of Health & Human Services have agreed to allow the remote prescription of some controlled substances through the end of 2024.
Federal agencies had earlier agreed to allow virtual providers to write prescriptions for drugs such as Oxycontin and Xanax until Nov. 11, 2023, and into 2024 for some patients. Last week, the DEA and health department said last week all prescriptions via telehealth would be allowed until the end of next year.
...Today's Sponsors
Today's Sponsor